Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. This appears to be a version bump with no visible changes to page content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.4.2. Removed the Notice about government funding lapse and the prior Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice about data currency and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedUI and metadata updates include showing the glossary toggle label, adding the 'Last Update Submitted that Met QC Criteria' field, and displaying 'Revision: v3.4.0' alongside the addition of 'No FEAR Act Data'. The core study details remain unchanged.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive study content appears to be altered.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section listing study sites by state and country, expanding geographic coverage. The revision is updated to v3.3.3.SummaryDifference2%

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.